Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors

AIDS

Volumn 14, Issue 3, 2000, Pages 235-236

  Huisman, Maarten T ^a   Smit, Johan W ^a   Schinkel, Alfred H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Blood brain barrier; HIV protease inhibitor; HIV transmission; P glycoprotein; Placenta

Indexed keywords

GLYCOPROTEIN P; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL;

ANTI-HIV AGENTS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; P-GLYCOPROTEINS;

EID: 0034054478     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200002180-00004     Document Type: Editorial

References (5)